Specialty Pharmaceutical Market Projected to Exceed USD 1532.8 Billion by 2033; Amid Rising Popularity of Advanced Therapeutics and Personalized Medicine
FDA Roundup: January 2, 2024
Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA
ImmunityBio Announces $320 Million Investment by Oberland Capital, with $210 Million Funded at Closing, Bringing Total Financing in 2023 to $850 Million
Valneva Provides Updated 2023 Financial Guidance
Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting
China Medical University Hospital's Breakthrough Drug of 'Allogenic mRNA CAR-T' & Its GenAI 'gHi' Standing Out in Healthcare+ Expo (Taiwan) 2023
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering
Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
 3   4   5   6   7     8    9   10   11   12   13 
 <<   <   >   >>